(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $2913.08 | $3316.14 | $3242.85 | |
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $81.58 | $69.46 | $49.9 | $32.37 |
Goodwill & intangible assets | $1.5 | $1.5 | $1.5 | |
Total noncurrent assets | ||||
Total investments | $25937.19 | $25019.07 | $24277.88 | |
Total assets | $31629.3 | $29854.99 | $29180.58 | $28356.27 |
Current liabilities | ||||
Accounts payable | $18.68 | $23.84 | $32.35 | $33.23 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $18.68 | $23.84 | $32.35 | $33.23 |
Long term debt | $660.17 | $660 | $859.82 | $859.15 |
Total noncurrent liabilities | ||||
Total debt | $2335 | $1609.82 | $2359.15 | |
Total liabilities | $28275.26 | $26679.39 | $26009.92 | $25157.12 |
Shareholders' equity | ||||
Retained earnings | $2428.94 | $2494.57 | $2457.22 | $2435.39 |
Other shareholder equity | -$16.49 | -$367.73 | -$379.89 | -$362 |
Total shareholder equity | $3175.6 | $3170.66 | $3199.14 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $3242.85 | $5012.26 | $7946.66 | $9206.38 |
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $32.37 | $26.38 | $76 | $92 |
Goodwill & intangible assets | $1.5 | $1.5 | $17.26 | $17.67 |
Total noncurrent assets | ||||
Total investments | $24277.88 | $22655.34 | $26187.02 | $27761.8 |
Total assets | $28356.27 | $28414.64 | $34732 | $37726 |
Current liabilities | ||||
Accounts payable | $33.23 | $24 | $8 | $11 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $33.23 | $24 | $77 | $94 |
Long term debt | $859.15 | $931.44 | $929 | $396 |
Total noncurrent liabilities | ||||
Total debt | $2359.15 | $2132.58 | $3131.57 | $3507.65 |
Total liabilities | $25157.12 | $25359.29 | $31522 | $34855 |
Shareholders' equity | ||||
Retained earnings | $2435.39 | $2263.5 | $1948 | $1713 |
Other shareholder equity | -$362 | -$66.39 | -$47.72 | $16 |
Total shareholder equity | $3199.14 | $3055.35 | $3209.62 | $2871.22 |
(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $247.01 | $237.33 | $245.85 | |
Cost of revenue | ||||
Gross Profit | $247.01 | $237.33 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $168.79 | $181.81 | ||
Total operating expenses | $188.41 | $202.39 | ||
Operating income | $58.6 | $34.94 | ||
Income from continuing operations | ||||
EBIT | $58.6 | $34.94 | ||
Income tax expense | $16.93 | $8.79 | $5.32 | |
Interest expense | ||||
Net income | ||||
Net income | $41.66 | $26.14 | $15.84 | |
Income (for common shares) | $37.35 | $21.83 |
(in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1075.54 | $1159.29 | $937.07 | $796.34 |
Cost of revenue | ||||
Gross Profit | $1159.29 | $937.07 | $796.34 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $658.53 | $510.5 | $554.25 | |
Total operating expenses | $727.53 | $599.01 | $704.4 | |
Operating income | $431.75 | $338.06 | $91.95 | |
Income from continuing operations | ||||
EBIT | $431.75 | $338.06 | $91.95 | |
Income tax expense | $57.45 | $99.28 | $84.12 | $25.66 |
Interest expense | ||||
Net income | ||||
Net income | $171.89 | $332.48 | $253.94 | $66.29 |
Income (for common shares) | $315.23 | $235.22 | $56.54 |
(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Net income | $41.66 | $26.14 | $20.15 | |
Operating activities | ||||
Depreciation | $13.93 | $10.91 | $9.6 | |
Business acquisitions & disposals | ||||
Stock-based compensation | $6.22 | $8.53 | $6.25 | |
Total cash flows from operations | $33.64 | $95.82 | $187.67 | |
Investing activities | ||||
Capital expenditures | -$22.2 | -$20.04 | -$3.73 | |
Investments | -$949.67 | -$789.92 | $322.15 | |
Total cash flows from investing | -$2238.74 | -$971.87 | -$809.96 | $318.41 |
Financing activities | ||||
Dividends paid | -$12.94 | |||
Sale and purchase of stock | -$49.81 | -$40.45 | -$44.56 | |
Net borrowings | $725 | -$750 | $100 | |
Total cash flows from financing | $2724.76 | $535.17 | $787.43 | -$1456.01 |
Effect of exchange rate | ||||
Change in cash and equivalents | $948.73 | -$403.06 | $73.29 | -$949.93 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $189.14 | $332.48 | $253.94 | $66.29 |
Operating activities | ||||
Depreciation | $40.47 | $45.28 | $93.41 | $74.92 |
Business acquisitions & disposals | $3324.16 | |||
Stock-based compensation | $24.2 | $21.43 | $31.33 | $17.44 |
Total cash flows from operations | $373.74 | $147.97 | $657.32 | $2639.87 |
Investing activities | ||||
Capital expenditures | -$16.38 | -$11.27 | -$4.13 | -$2.8 |
Investments | -$1739.1 | -$4.32 | $1236.91 | -$2932.52 |
Total cash flows from investing | -$1755.48 | $3308.57 | $1232.79 | -$2935.32 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | -$109.24 | -$119.51 | ||
Net borrowings | $223.86 | -$1001.69 | -$380.48 | $569.99 |
Total cash flows from financing | -$387.67 | -$6390.94 | -$3149.82 | $5076.24 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$1769.41 | -$2934.4 | -$1259.72 | $4780.8 |
Market cap | $4.14B |
---|---|
Enterprise value | N/A |
Shares outstanding | 46.21M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 7.86 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |